心包疾病:多模态心脏影像新概念与新进展的国际立场声明
该国际立场声明由心包领域国际专家撰写,聚焦复发性、一过性缩窄性和渗出-缩窄性心包炎等多模态心脏影像诊断新概念,以及针对炎症小体的抗IL-1药物等靶向治疗进展,指出现有影像与临床指南已超8-10年,并引用AIRTRIP、RHAPSODY等试验显示抗IL-1药物疗效。
要点
- 多模态心脏影像可用于识别复发性、一过性缩窄性和渗出-缩窄性心包炎等新概念。
- 抗IL-1药物(阿那白滞素、利洛纳塞、戈利基塞普特)在复发性心包炎试验中显示疗效。
- 现有心包影像与临床指南已超8-10年,可能未反映当前实践。
核心结论
- 该国际立场声明聚焦心包疾病多模态心脏影像与新型靶向治疗的新概念和新进展。
研究设计与样本
- 该文件为心包领域国际专家撰写的国际立场声明。
临床应用与阅片要点
- 该声明强调多模态心脏影像在心包疾病评估中的作用。
- 该声明强调新型靶向治疗(尤其抗IL-1药物)在心包疾病中的作用。
局限性
- 现有心包影像指南(美国超声心动图学会、欧洲心血管影像协会)和临床指南(欧洲心脏病学会)已超8-10年,可能未反映当前实践。
- 临床医生存在较大的教育差距,导致这些患者的评估和管理存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Pericardial diseases have gained renewed clinical interest, leading to a renaissance in the field. There have been many recent advances in pericardial diseases in both multimodality cardiac imaging of diagnoses, such as recurrent, transient constrictive and effusive-constrictive pericarditis, and targeted therapeutics, especially anti-interleukin (IL)-1 agents that affect the inflammasome as part of autoinflammatory pathophysiology. There remains a large educational gap for clinicians, leading to variability in evaluation and management of these patients. The latest pericardial imaging (American Society of Echocardiography, European Association of Cardiovascular Imaging) and clinical guidelines (European Society of Cardiology) are >8-10 years of age and may not reflect current practice. Recent clinical trials involving anti-IL-1 agents in recurrent pericarditis, including anakinra (AIRTRIP), rilonacept (RHAPSODY), and goflikicept have demonstrated their efficacy. The present document represents an international position statement from world leaders in the pericardial field, focusing on novel concepts and emphasizing the role of multimodality cardiac imaging as well as new therapeutics in pericardial diseases.
引用
- Klein AL, Wang TKM, Cremer PC, et al. Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging. JACC Cardiovasc Imaging. 2024. PMID: 39111992. doi:10.1016/j.jcmg.2024.04.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。